Bharat Seats Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 27, 2025, 11:05 pm

Market Cap	441 Cr.
Current Price	70.2
High / Low	125/62.8
Stock P/E	15.0
Book Value	27.9
Dividend Yield	1.14 %
ROCE	15.3 %
ROE	15.9 %
Face Value	2.00
PEG Ratio	0.36

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Bharat Seats Ltd

Competitors of Bharat Seats Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
G S Auto International Ltd	50.2 Cr.	34.6	54.8/29.5	30.6	15.6	0.00 %	10.1 %	3.21 %	5.00
Duncan Engineering Ltd	109 Cr.	295	902/277	18.3	149	1.19 %	18.4 %	13.9 %	10.0
Bharat Seats Ltd	441 Cr.	70.2	125/62.8	15.0	27.9	1.14 %	15.3 %	15.9 %	2.00
Automobile Corporation of Goa Ltd	675 Cr.	1,108	3,449/1,064	16.6	387	1.80 %	18.7 %	18.6 %	10.0
Akar Auto Industries Ltd	117 Cr.	109	149/87.8	19.0	44.4	0.55 %	17.3 %	13.1 %	5.00
Industry Average	3,975.21 Cr	483.25		30.14	145.63	0.86%	16.36%	15.36%	5.80

All Competitor Stocks of Bharat Seats Ltd

Quarterly Result

Metric	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	190.88	197.56	260.95	247.69	290.75	219.18	293.43	252.75	285.98	249.98	278.10	298.85	290.67
Expenses	184.63	189.50	247.29	238.20	278.82	209.03	278.77	240.66	269.04	235.33	260.98	282.34	273.01
Operating Profit	6.25	8.06	13.66	9.49	11.93	10.15	14.66	12.09	16.94	14.65	17.12	16.51	17.66
OPM %	3.27%	4.08%	5.23%	3.83%	4.10%	4.63%	5.00%	4.78%	5.92%	5.86%	6.16%	5.52%	6.08%
Other Income	1.43	0.65	1.38	0.34	0.97	1.44	1.35	1.09	0.84	1.45	1.16	0.95	0.70
Interest	0.99	1.21	0.86	0.71	0.83	0.91	1.18	1.38	2.38	2.24	1.75	2.23	2.27
Depreciation	4.43	4.35	4.37	4.34	4.21	4.21	4.32	5.41	6.30	6.29	6.01	6.35	6.50
Profit before tax	2.26	3.15	9.81	4.78	7.86	6.47	10.51	6.39	9.10	7.57	10.52	8.88	9.59
Tax %	25.22%	25.40%	24.16%	25.52%	25.32%	26.74%	29.88%	26.92%	25.49%	27.08%	23.29%	25.56%	25.96%
Net Profit	1.69	2.36	7.44	3.56	5.87	4.75	7.37	4.67	6.79	5.52	8.08	6.61	7.10
EPS in Rs	0.27	0.38	1.18	0.57	0.93	0.76	1.17	0.74	1.08	0.88	1.29	1.05	1.13

Last Updated: January 5, 2025, 8:33 am

Below is a detailed analysis of the quarterly data for Bharat Seats Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Sales, as of Sep 2024, the value is ₹290.67 Cr.. The value appears to be declining and may need further review. It has decreased from ₹298.85 Cr. (Jun 2024) to ₹290.67 Cr., marking a decrease of ₹8.18 Cr..
For Expenses, as of Sep 2024, the value is ₹273.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from ₹282.34 Cr. (Jun 2024) to ₹273.01 Cr., marking a decrease of ₹9.33 Cr..
For Operating Profit, as of Sep 2024, the value is ₹17.66 Cr.. The value appears strong and on an upward trend. It has increased from ₹16.51 Cr. (Jun 2024) to ₹17.66 Cr., marking an increase of ₹1.15 Cr..
For OPM %, as of Sep 2024, the value is 6.08%. The value appears strong and on an upward trend. It has increased from 5.52% (Jun 2024) to 6.08%, marking an increase of 0.56%.
For Other Income, as of Sep 2024, the value is ₹0.70 Cr.. The value appears to be declining and may need further review. It has decreased from ₹0.95 Cr. (Jun 2024) to ₹0.70 Cr., marking a decrease of ₹0.25 Cr..
For Interest, as of Sep 2024, the value is ₹2.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹2.23 Cr. (Jun 2024) to ₹2.27 Cr., marking an increase of ₹0.04 Cr..
For Depreciation, as of Sep 2024, the value is ₹6.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹6.35 Cr. (Jun 2024) to ₹6.50 Cr., marking an increase of ₹0.15 Cr..
For Profit before tax, as of Sep 2024, the value is ₹9.59 Cr.. The value appears strong and on an upward trend. It has increased from ₹8.88 Cr. (Jun 2024) to ₹9.59 Cr., marking an increase of ₹0.71 Cr..
For Tax %, as of Sep 2024, the value is 25.96%. The value appears to be increasing, which may not be favorable. It has increased from 25.56% (Jun 2024) to 25.96%, marking an increase of 0.40%.
For Net Profit, as of Sep 2024, the value is ₹7.10 Cr.. The value appears strong and on an upward trend. It has increased from ₹6.61 Cr. (Jun 2024) to ₹7.10 Cr., marking an increase of ₹0.49 Cr..
For EPS in Rs, as of Sep 2024, the value is ₹1.13. The value appears strong and on an upward trend. It has increased from ₹1.05 (Jun 2024) to ₹1.13, marking an increase of ₹0.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	600	560	693	700	840	970	904	589	548	818	1,051	1,067	1,113
Expenses	576	531	661	670	803	905	853	553	521	785	1,005	1,006	1,048
Operating Profit	24	29	32	30	37	65	50	36	27	32	46	61	65
OPM %	4%	5%	5%	4%	4%	7%	6%	6%	5%	4%	4%	6%	6%
Other Income	1	0	2	2	1	1	5	2	2	5	4	5	4
Interest	6	6	6	5	4	3	3	3	4	4	4	8	9
Depreciation	11	14	16	17	17	19	21	22	18	18	17	24	25
Profit before tax	7	9	11	10	17	44	31	12	7	16	30	34	36
Tax %	24%	26%	29%	27%	28%	35%	31%	-2%	28%	25%	27%	25%
Net Profit	5	7	8	7	12	28	21	13	5	12	22	25	27
EPS in Rs	1.70	2.14	2.59	2.30	3.88	8.99	6.82	3.99	1.53	3.79	6.86	7.98	8.60
Dividend Payout %	47%	37%	35%	39%	23%	11%	15%	13%	33%	21%	20%	20%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	40.00%	14.29%	-12.50%	71.43%	133.33%	-25.00%	-38.10%	-61.54%	140.00%	83.33%	13.64%
Change in YoY Net Profit Growth (%)	0.00%	-25.71%	-26.79%	83.93%	61.90%	-158.33%	-13.10%	-23.44%	201.54%	-56.67%	-69.70%

Bharat Seats Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	7%
5 Years:	3%
3 Years:	25%
TTM:	8%

Compounded Profit Growth
10 Years:	14%
5 Years:	3%
3 Years:	76%
TTM:	21%

Stock Price CAGR
10 Years:	16%
5 Years:	22%
3 Years:	28%
1 Year:	-15%

Return on Equity
10 Years:	16%
5 Years:	12%
3 Years:	14%
Last Year:	16%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 5:42 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	6	6	6	6	6	6	6	6	6	6	6	6	6
Reserves	32	35	40	47	56	80	98	107	110	121	140	161	169
Borrowings	105	102	91	75	63	25	29	40	35	39	66	160	168
Other Liabilities	79	109	127	122	140	172	140	89	140	171	146	179	199
Total Liabilities	221	253	265	250	265	285	273	242	291	337	358	505	542
Fixed Assets	112	150	150	144	146	136	152	150	126	147	199	276	268
CWIP	32	4	3	1	0	13	0	22	30	8	12	49	82
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	78	99	111	104	119	135	121	69	135	182	147	181	192
Total Assets	221	253	265	250	265	285	273	242	291	337	358	505	542

Below is a detailed analysis of the balance sheet data for Bharat Seats Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹6.00 Cr..
For Reserves, as of Sep 2024, the value is ₹169.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹161.00 Cr. (Mar 2024) to ₹169.00 Cr., marking an increase of ₹8.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹168.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹160.00 Cr. (Mar 2024) to ₹168.00 Cr., marking an increase of ₹8.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹199.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹179.00 Cr. (Mar 2024) to ₹199.00 Cr., marking an increase of ₹20.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹542.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹505.00 Cr. (Mar 2024) to ₹542.00 Cr., marking an increase of ₹37.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹268.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹276.00 Cr. (Mar 2024) to ₹268.00 Cr., marking a decrease of ₹8.00 Cr..
For CWIP, as of Sep 2024, the value is ₹82.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹49.00 Cr. (Mar 2024) to ₹82.00 Cr., marking an increase of ₹33.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹192.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹181.00 Cr. (Mar 2024) to ₹192.00 Cr., marking an increase of ₹11.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹542.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹505.00 Cr. (Mar 2024) to ₹542.00 Cr., marking an increase of ₹37.00 Cr..

Notably, the Reserves (₹169.00 Cr.) exceed the Borrowings (₹168.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	5	36	36	34	38	69	35	28	19	16	43	57
Cash from Investing Activity +	-37	-17	-13	-6	-17	-23	-24	-34	-12	-15	-59	-73
Cash from Financing Activity +	29	-18	-23	-28	-22	-44	-4	-3	-7	-2	17	16
Net Cash Flow	-3	0	0	0	0	2	7	-9	-0	-1	0	-0

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-81.00	-73.00	-59.00	-45.00	-26.00	40.00	21.00	-4.00	-8.00	-7.00	-20.00	-99.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	31	43	40	43	41	35	31	22	55	49	34	35
Inventory Days	10	8	7	9	8	12	11	16	24	28	12	16
Days Payable	41	59	56	60	61	66	59	57	99	68	48	61
Cash Conversion Cycle	-1	-8	-8	-8	-13	-19	-17	-19	-20	9	-3	-9
Working Capital Days	-10	-19	-19	-18	-12	-13	-9	-12	-10	4	-3	-3
ROCE %	11%	11%	13%	12%	17%	40%	28%	11%	7%	12%	18%	15%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	74.59%	74.59%	74.59%	74.59%	74.59%	74.59%	74.59%	74.59%	74.59%	74.59%	74.59%	74.59%
DIIs	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%
Public	25.30%	25.30%	25.30%	25.30%	25.30%	25.30%	25.30%	25.29%	25.30%	25.30%	25.31%	25.30%
No. of Shareholders	13,253	12,769	12,223	12,090	11,842	12,783	13,127	13,410	14,894	15,121	16,677	27,016

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	7.98	6.86	3.79	1.53	3.99
Diluted EPS (Rs.)	7.98	6.86	3.79	1.53	3.99
Cash EPS (Rs.)	15.62	12.30	9.40	7.26	11.14
Book Value[Excl.RevalReserv]/Share (Rs.)	53.13	46.60	40.49	37.14	36.08
Book Value[Incl.RevalReserv]/Share (Rs.)	53.13	46.60	40.49	37.14	36.08
Dividend / Share (Rs.)	1.60	1.40	0.80	0.50	0.50
Revenue From Operations / Share (Rs.)	339.75	334.73	260.39	174.41	187.44
PBDIT / Share (Rs.)	20.80	16.03	11.92	9.20	12.07
PBIT / Share (Rs.)	13.16	10.59	6.31	3.48	4.92
PBT / Share (Rs.)	10.69	9.44	5.07	2.12	3.89
Net Profit / Share (Rs.)	7.98	6.86	3.79	1.53	3.99
PBDIT Margin (%)	6.12	4.78	4.57	5.27	6.43
PBIT Margin (%)	3.87	3.16	2.42	1.99	2.62
PBT Margin (%)	3.14	2.81	1.94	1.21	2.07
Net Profit Margin (%)	2.34	2.05	1.45	0.87	2.12
Return on Networth / Equity (%)	15.01	14.72	9.37	4.12	11.04
Return on Capital Employeed (%)	14.13	17.42	11.75	7.26	10.11
Return On Assets (%)	4.95	6.02	3.53	1.64	5.17
Long Term Debt / Equity (X)	0.31	0.22	0.25	0.21	0.21
Total Debt / Equity (X)	0.52	0.40	0.29	0.25	0.27
Asset Turnover Ratio (%)	2.47	3.02	2.60	2.05	2.29
Current Ratio (X)	0.76	0.78	1.03	0.86	0.69
Quick Ratio (X)	0.57	0.61	0.71	0.65	0.46
Inventory Turnover Ratio (X)	25.91	22.01	16.85	17.83	21.65
Dividend Payout Ratio (NP) (%)	17.54	11.65	13.17	32.66	25.08
Dividend Payout Ratio (CP) (%)	8.96	6.50	5.31	6.88	8.97
Earning Retention Ratio (%)	82.46	88.35	86.83	67.34	74.92
Cash Earning Retention Ratio (%)	91.04	93.50	94.69	93.12	91.03
Interest Coverage Ratio (X)	8.44	13.85	9.59	6.76	11.76
Interest Coverage Ratio (Post Tax) (X)	4.24	6.93	4.05	2.12	4.88
Enterprise Value (Cr.)	538.61	313.58	245.72	222.69	141.59
EV / Net Operating Revenue (X)	0.50	0.29	0.30	0.40	0.24
EV / EBITDA (X)	8.24	6.23	6.56	7.71	3.74
MarketCap / Net Operating Revenue (X)	0.42	0.24	0.25	0.35	0.18
Retention Ratios (%)	82.45	88.34	86.82	67.33	74.91
Price / BV (X)	2.70	1.74	1.65	1.67	0.98
Price / Net Operating Revenue (X)	0.42	0.24	0.25	0.35	0.18
EarningsYield	0.05	0.08	0.05	0.02	0.11

After reviewing the key financial ratios for Bharat Seats Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 7.98. This value is within the healthy range. It has increased from 6.86 (Mar 23) to 7.98, marking an increase of 1.12.
For Diluted EPS (Rs.), as of Mar 24, the value is 7.98. This value is within the healthy range. It has increased from 6.86 (Mar 23) to 7.98, marking an increase of 1.12.
For Cash EPS (Rs.), as of Mar 24, the value is 15.62. This value is within the healthy range. It has increased from 12.30 (Mar 23) to 15.62, marking an increase of 3.32.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 53.13. It has increased from 46.60 (Mar 23) to 53.13, marking an increase of 6.53.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 53.13. It has increased from 46.60 (Mar 23) to 53.13, marking an increase of 6.53.
For Dividend / Share (Rs.), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 1.40 (Mar 23) to 1.60, marking an increase of 0.20.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 339.75. It has increased from 334.73 (Mar 23) to 339.75, marking an increase of 5.02.
For PBDIT / Share (Rs.), as of Mar 24, the value is 20.80. This value is within the healthy range. It has increased from 16.03 (Mar 23) to 20.80, marking an increase of 4.77.
For PBIT / Share (Rs.), as of Mar 24, the value is 13.16. This value is within the healthy range. It has increased from 10.59 (Mar 23) to 13.16, marking an increase of 2.57.
For PBT / Share (Rs.), as of Mar 24, the value is 10.69. This value is within the healthy range. It has increased from 9.44 (Mar 23) to 10.69, marking an increase of 1.25.
For Net Profit / Share (Rs.), as of Mar 24, the value is 7.98. This value is within the healthy range. It has increased from 6.86 (Mar 23) to 7.98, marking an increase of 1.12.
For PBDIT Margin (%), as of Mar 24, the value is 6.12. This value is below the healthy minimum of 10. It has increased from 4.78 (Mar 23) to 6.12, marking an increase of 1.34.
For PBIT Margin (%), as of Mar 24, the value is 3.87. This value is below the healthy minimum of 10. It has increased from 3.16 (Mar 23) to 3.87, marking an increase of 0.71.
For PBT Margin (%), as of Mar 24, the value is 3.14. This value is below the healthy minimum of 10. It has increased from 2.81 (Mar 23) to 3.14, marking an increase of 0.33.
For Net Profit Margin (%), as of Mar 24, the value is 2.34. This value is below the healthy minimum of 5. It has increased from 2.05 (Mar 23) to 2.34, marking an increase of 0.29.
For Return on Networth / Equity (%), as of Mar 24, the value is 15.01. This value is within the healthy range. It has increased from 14.72 (Mar 23) to 15.01, marking an increase of 0.29.
For Return on Capital Employeed (%), as of Mar 24, the value is 14.13. This value is within the healthy range. It has decreased from 17.42 (Mar 23) to 14.13, marking a decrease of 3.29.
For Return On Assets (%), as of Mar 24, the value is 4.95. This value is below the healthy minimum of 5. It has decreased from 6.02 (Mar 23) to 4.95, marking a decrease of 1.07.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.31. This value is within the healthy range. It has increased from 0.22 (Mar 23) to 0.31, marking an increase of 0.09.
For Total Debt / Equity (X), as of Mar 24, the value is 0.52. This value is within the healthy range. It has increased from 0.40 (Mar 23) to 0.52, marking an increase of 0.12.
For Asset Turnover Ratio (%), as of Mar 24, the value is 2.47. It has decreased from 3.02 (Mar 23) to 2.47, marking a decrease of 0.55.
For Current Ratio (X), as of Mar 24, the value is 0.76. This value is below the healthy minimum of 1.5. It has decreased from 0.78 (Mar 23) to 0.76, marking a decrease of 0.02.
For Quick Ratio (X), as of Mar 24, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.61 (Mar 23) to 0.57, marking a decrease of 0.04.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 25.91. This value exceeds the healthy maximum of 8. It has increased from 22.01 (Mar 23) to 25.91, marking an increase of 3.90.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 17.54. This value is below the healthy minimum of 20. It has increased from 11.65 (Mar 23) to 17.54, marking an increase of 5.89.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 8.96. This value is below the healthy minimum of 20. It has increased from 6.50 (Mar 23) to 8.96, marking an increase of 2.46.
For Earning Retention Ratio (%), as of Mar 24, the value is 82.46. This value exceeds the healthy maximum of 70. It has decreased from 88.35 (Mar 23) to 82.46, marking a decrease of 5.89.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 91.04. This value exceeds the healthy maximum of 70. It has decreased from 93.50 (Mar 23) to 91.04, marking a decrease of 2.46.
For Interest Coverage Ratio (X), as of Mar 24, the value is 8.44. This value is within the healthy range. It has decreased from 13.85 (Mar 23) to 8.44, marking a decrease of 5.41.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.24. This value is within the healthy range. It has decreased from 6.93 (Mar 23) to 4.24, marking a decrease of 2.69.
For Enterprise Value (Cr.), as of Mar 24, the value is 538.61. It has increased from 313.58 (Mar 23) to 538.61, marking an increase of 225.03.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.50. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.50, marking an increase of 0.21.
For EV / EBITDA (X), as of Mar 24, the value is 8.24. This value is within the healthy range. It has increased from 6.23 (Mar 23) to 8.24, marking an increase of 2.01.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 23) to 0.42, marking an increase of 0.18.
For Retention Ratios (%), as of Mar 24, the value is 82.45. This value exceeds the healthy maximum of 70. It has decreased from 88.34 (Mar 23) to 82.45, marking a decrease of 5.89.
For Price / BV (X), as of Mar 24, the value is 2.70. This value is within the healthy range. It has increased from 1.74 (Mar 23) to 2.70, marking an increase of 0.96.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 23) to 0.42, marking an increase of 0.18.
For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 23) to 0.05, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Bharat Seats Ltd as of February 28, 2025 is: ₹53.84

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 28, 2025, Bharat Seats Ltd is Overvalued by 23.30% compared to the current share price 70.20

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Bharat Seats Ltd as of February 28, 2025 is: 76.04

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 28, 2025, Bharat Seats Ltd is Undervalued by 8.32% compared to the current share price ₹70.20

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: 41.24%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 16.25%, which is a positive sign. The stock has a low average Working Capital Days of -10.33, which is a positive sign. The stock has a low average Cash Conversion Cycle of -9.67, which is a positive sign. The company has higher reserves (92.00 cr) compared to borrowings (76.77 cr), indicating strong financial stability. The company has shown consistent growth in sales (555.77 cr) and profit (20.31 cr) over the years.

Strength

Weakness

The stock has a high average ROCE of 16.25%, which is a positive sign.
The stock has a low average Working Capital Days of -10.33, which is a positive sign.
The stock has a low average Cash Conversion Cycle of -9.67, which is a positive sign.
The company has higher reserves (92.00 cr) compared to borrowings (76.77 cr), indicating strong financial stability.
The company has shown consistent growth in sales (555.77 cr) and profit (20.31 cr) over the years.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bharat Seats Ltd:
1. Net Profit Margin: 2.34%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 14.13% (Industry Average ROCE: 16.36%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 15.01% (Industry Average ROE: 14.59%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 4.24
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.57
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 15 (Industry average Stock P/E: 27.13)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.52
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Bharat Seats Ltd. is a Public Limited Listed company incorporated on 06/03/1986 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L34300DL1986PLC023540 and registration number is 023540. Currently Company is involved in the business activities of Manufacture of parts and accessories for motor vehicles. Company's Total Operating Revenue is Rs. 1066.82 Cr. and Equity Capital is Rs. 6.28 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Auto Ancl - Others	1, Nelson Mandela Road, New Delhi Delhi 110070	investor_relations@bharatseats.net http://www.bharatseats.com

Management
Name	Position Held
Mr. Rohit Relan	Chairman & Managing Director
Mr. Rishabh Relan	Whole Time Director
Ms. Nisha Malhotra	Independent Director
Mrs. Shyamla Khera	Independent Director
Mr. Arvind Varma	Independent Director
Mr. Sanjay Bhattacharyya	Independent Director
Mr. Sudhir Maheshwari	Independent Director
Ms. Vanita Chhabra	Independent Director
Mr. Raman Venkat Challa	Nominee Director
Mr. Makoto Kunieda	Nominee Director

FAQ

What is the latest intrinsic value of Bharat Seats Ltd?

Let's break down Bharat Seats Ltd's intrinsic value simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 28 February 2025:

Calculated Fair Value: ₹53.84
Current Market Price: ₹70.20
Variance: 23.30% lower

This suggests Bharat Seats Ltd is currently overvalued by 23.30%. For context:

Market Cap: 441 Cr.
52-Week Range: 125/62.8
Reserves (Sep 2024): 169 Cr
Liabilities: 542 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of Bharat Seats Ltd?

The Market Cap of Bharat Seats Ltd is 441 Cr..

What is the current Stock Price of Bharat Seats Ltd as on 28 February 2025?

The current stock price of Bharat Seats Ltd as on 28 February 2025 is ₹70.2.

What is the High / Low of Bharat Seats Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Bharat Seats Ltd stocks is 125/62.8.

What is the Stock P/E of Bharat Seats Ltd?

The Stock P/E of Bharat Seats Ltd is 15.0.

What is the Book Value of Bharat Seats Ltd?

The Book Value of Bharat Seats Ltd is 27.9.

What is the Dividend Yield of Bharat Seats Ltd?

The Dividend Yield of Bharat Seats Ltd is 1.14 %.

What is the ROCE of Bharat Seats Ltd?

The ROCE of Bharat Seats Ltd is 15.3 %.

What is the ROE of Bharat Seats Ltd?

The ROE of Bharat Seats Ltd is 15.9 %.

What is the Face Value of Bharat Seats Ltd?

The Face Value of Bharat Seats Ltd is 2.00.